Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Risk Factors Associated with Leishmaniasis among Residents of Rural Marigat Sub-County, Baringo County - Kenya

Philipo Gwandi M, Odongo AO, Kirira PG, et al. Sciencedomain International. International Journal of TROPICAL DISEASE & Health. 2022;
Download PDF
Publication

To eliminate trachoma: Azithromycin mass drug administration coverage and associated factors among adults in Goro district, Southeast Ethiopia

Feyisa T, Bekele D, Tura B, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (6) : e0010169.
Download PDF
Publication

Integration of machine learning algorithms and GIS-based approaches to cutaneous leishmaniasis prevalence risk mapping

Shabanpour N, Razavi-Termeh SV, Sadeghi-Niaraki A, et al. Elsevier BV. International Journal of Applied Earth Observation and Geoinformation. 2022;
Download PDF
Publication

What fuels the research truck? Participatory health promotion research for sustainable change

Rod MH, Aagaard-Hansen J, Bauman A, et al. Oxford University Press (OUP). Health Promotion International. 2022; 37 (Supplement_2) : ii1-ii6.
Download PDF
Publication

Mass drug administration of antibacterials: weighing the evidence regarding benefits and risks

Rolfe RJ, Shaikh H, Tillekeratne LG. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2022;
Download PDF
Publication

New declaration on neglected tropical diseases endorsed

Burki T. Elsevier BV. The Lancet. 2022; 400 (10345) : 15.
Publication

Mass drug administration for lymphatic filariasis elimination amidst COVID-19 pandemic in Odisha, India: A step towards achieving SDG-3

Sinha A, Mohapatra S, Mohanty S, et al. SAGE Publications. Tropical Doctor. 2022;
Download PDF
Publication

Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.

Sabesan S, Krishnamoorthy K, Hoti S, et al. The Indian journal of medical research. 2022;
Download PDF
Publication

Validation of a Culturally Relevant Snakebite Envenomation Clinical Practice Guideline in Brazil.

Rocha G, Farias A, Alcântara J, et al. Toxins. 2022;
Download PDF
Publication

Scaling up of tsetse control to eliminate Gambian sleeping sickness in northern Uganda.

Hope A, Mugenyi A, Esterhuizen J, et al. PLoS neglected tropical diseases. 2022; 16 (6) : e0010222.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 271
  • Next page ››
Subscribe to Full text online

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2026 InfoNTD